Page last updated: 2024-08-25

rosiglitazone and Hematologic Diseases

rosiglitazone has been researched along with Hematologic Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McMorran, M; Vu, D1

Other Studies

1 other study(ies) available for rosiglitazone and Hematologic Diseases

ArticleYear
Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2001, Jul-10, Volume: 165, Issue:1

    Topics: Aged; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Female; Hematologic Diseases; Humans; Hypoglycemic Agents; Liver Failure; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones

2001